CD274 and neoplasm: Furthermore, we investigated the antitumor efficacy of the combined immunotherapy with DB, TIGIT and PD-L1 blockades in vitro and in vivo using our resistant murine tumor model of NB, followed by an evaluation of tumor infiltrating effector cells with a special focus on MDSCs.